抗瓜氨酸化肽抗体表位扩展与HLA DRB1共享表位在血清阳性检查点抑制剂诱导的炎症性关节炎中较长期类风湿关节炎少见
本研究比较了CCP阳性的ICI相关炎症性关节炎(ICI-IA)患者与早期及长期类风湿关节炎(RA)患者的ACPA表位扩展程度,并对ICI-IA患者及未发生ICI-IA的ICI对照进行HLA DRB1分型。结果显示,与长期RA相比,ICI-IA患者ACPA水平更低、针对的ACPA表位数更少(p<0.001);ICI-IA与ICI对照间共享表位频率无差异。
要点
- 与长期RA相比,ICI-IA患者ACPA水平更低、针对的ACPA表位数更少(p<0.001)。
- ICI-IA与ICI对照间HLA DRB1共享表位频率无差异。
- ICI-IA是否代表ICI触发的RA加速模型尚待确定。
核心结论
- ICI-IA患者较长期RA患者ACPA滴度更低且针对的ACPA表位更少,ICI-IA与ICI对照间共享表位存在率无显著差异。
- ICI-IA是否代表ICI触发从临床前到临床疾病的RA发病加速模型尚待确定。
研究设计与样本
- 使用ICI-IA患者以及早期和长期RA患者的临床数据和血清。
- 采用定制珠基抗原阵列检测针对18种推定RA相关瓜氨酸化蛋白的IgG ACPA反应性,并用层次聚类软件创建热图以识别ACPA水平。
- 对ICI-IA患者及未发生ICI-IA的ICI治疗对照进行HLA DRB1分型。
主要发现
- 与CCP+RA患者相比,CCP+ICI-IA患者年龄更大(p<0.001)、类风湿因子阳性可能性更低(p<0.001)且症状持续时间更短(p<0.001)。
- 与长期RA患者相比,ICI-IA患者血清中ACPA水平更少且不同ACPA表位数更少(p<0.001)。
- 在接受HLA DRB1检测者中,ICI-IA与ICI对照间共享表位频率无差异。
局限性
- ICI-IA是否代表ICI触发从临床前到临床疾病的RA发病加速模型尚待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune checkpoint inhibitors (ICI) can potentially cause ICI-inflammatory arthritis (ICI-IA), which often resembles rheumatoid arthritis (RA). In this study, we examined the degree of anticitrullinated peptide antibodies (ACPA) epitope expansion in CCP+ICI-IA and patients with RA. METHODS: We used clinical data and serum from ICI-IA and patients with RA with early disease as well as longstanding disease. A custom, bead-based antigen array was used to identify IgG ACPA reactivities to 18 putative RA-associated citrullinated proteins. Hierarchical clustering software was used to create a heatmap to identify ACPA levels. Additionally, HLA DRB1 typing was performed on ICI-IA patients as well as controls of patients treated with ICI that did not develop ICI-IA (ICI controls). RESULTS: Compared to patients with CCP+RA, patients with CCP+ICI-IA were older (p<0.001), less likely to have positive rheumatoid factor (p<0.001) and had a shorter duration of symptoms (p<0.001). There were less ACPA levels and a lower number of distinct ACPA epitopes in the serum of patients with ICI-IA compared with longstanding patients with RA (p<0.001). Among those tested for HLA DRB1, there were no differences in the frequency of the shared epitope between those with ICI-IA and ICI controls. CONCLUSION: Patients with ICI-IA had lower ACPA titres and targeted fewer ACPA epitopes than longstanding patients with RA, and there were no significant differences in the presence of the shared epitope between those that developed ICI-IA and ICI controls. It remains to be determined if ICI-IA represents an accelerated model of RA pathogenesis with ICI triggering a transition from preclinical to clinical disease.
引用
- Ghosh N, Reid P, Aude CA, et al. Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD Open. 2023. PMID: 37355249. doi:10.1136/rmdopen-2023-003012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。